Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

Leukemia

Volumn 15, Issue 6, 2001, Pages 963-970

  Seiter, K ^a,b   Feldman, E J ^a,b   Sreekantaiah, C ^c   Pozzuoli, M ^a,b   Weisberger, J ^c   Liu, D ^a,b   Papageorgio, C ^a,b   Weiss, M ^d   Kancherla, R ^a,b   Ahmed, T ^a,b  

^a Division of Oncology   (United States)

^b Zalmen A Arlin Cancer Institute   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cytogenetics; Leukemia; MDS; Mitoxantone

Indexed keywords

ASPARAGINASE; CYTARABINE; ETOPOSIDE; GYRASE INHIBITOR; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; DRUG EXPOSURE; DRUG MEGADOSE; EVALUATION; FEMALE; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; PRIORITY JOURNAL;

EID: 0034986617     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402122     Document Type: Article

References (37)

1. Intensive postremission chemotherapy in adults with acute myeloid leukemia
2. Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: A review and updated results of the Australian Leukemia Study Group
3. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission: Results of MRC AML 10 trial
4. Autologous or allogeneic bone marrow transplantation compared to intensive chemotherapy in acute myelogenous leukemia
5. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia
6. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations
7. Rearrangements of the MLL gene in therapy-related acute myelogenous leukemia in patients previously treated with agents targeting DNA-topoisomerase II
8. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells
9. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis
10. Therapy-related acute promyelocytic leukemia: A report on 16 cases
11. Therapy-related acute myeloid leukemia with t(8;21), inv 16, and t(8;16). A report on 25 cases and review of the literature
12. Chemotherapy-related and late occurring Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?
13. Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation
14. Spontaneous resolution of myelodysplastic cytogenetic abnormality developed during the treatment of leukemia
15. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by peritoneal administration
16. Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia
17. Short course high-dose mitoxantrone with high-dose cytarabine is effective therapy for adult lymphoblastic leukemia
18. A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
19. A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia
20. Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukemia
21. Cytarabine with high-dose mitoxantrone induces rapid complete remission in adult acute lymphoblastic leukemia without the use of vincristine or prednisone
22. High resolution of human chromosomes
23. A rapid banding technique for human chromosomes
24. Therapy-related myelodysplastic syndrome in adults with neurofibromatosis
25. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases
26. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias
27. Molecular anatomy of chromosome 7q deletions in myeloid malignancies: Evidence for multiple critical loci
28. Myeloid malignancies induced by alkylating agents in Nf1 mice
29. Hematologic disorders associated with deletions of chromosome 20q
30. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders
31. De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: A subtype of MDS with distinct hematologic and prognostic features?
32. Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q
33. Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?
34. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature
35. The Philadelphia chromosome as a secondary change in leukemia: Three case reports and an overview of the literature
36. Late-appearing Philadelphia chromosome in a patient with acute non-lymphocytic leukemia derived from myelodysplastic syndrome: Detection of P210- and P190-type bcr/abl fusion gene transcripts at the leukaemic stage